We examined a panel of cell lines for their steady-state levels of UBE2R1 and UBE2R2 and noticed low levels of UBE2R2 in multiple cell lines including the breast cancer cell line MDA-MB-468 (Figure 3A; Excel File S2). This evidence concerns the gene CDC34 and breast carcinoma.